SCHEMBL23198328

SCHEMBL23198328

[CH2]c1ccc(Cl)c(NCCc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
PKM P14618 1/20 0.43
FAAH O00519 1/20 0.42
MGLL Q99685 1/20 0.42
RAB9A P51151 3/20 0.41
NSD2 O96028 1/20 0.41
HSP90AA1 P07900 1/20 0.41
G6PD P11413 1/20 0.41
CCR6 P51684 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
TLR9 Q9NR96 1/20 0.41
GPR84 Q9NQS5 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 3/20 0.40
MAPT P10636 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3907119 0.79 L3MBTL1 (0.53) CCNCCDK8L3MBTL1PKMRAB9A
SCHEMBL8154788 0.72 ABL1 (0.49) GPR84MAPTSMN1; SMN2
SCHEMBL7835625 0.72 L3MBTL1 (0.70) L3MBTL1RAB9AKDM4EMEN1MAPT
SCHEMBL897466 0.72 L3MBTL1 (0.53) L3MBTL1PKMRAB9AKDM4EMEN1
SCHEMBL3909660 0.71 L3MBTL1 (0.58) L3MBTL1FAAHMGLLMEN1MAPT
SCHEMBL2762378 0.71 L3MBTL1 (0.63) L3MBTL1RAB9AGPR84MAPTALDH1A1
SCHEMBL3711850 0.71 L3MBTL1 (0.49) CCNCCDK8L3MBTL1PKMRAB9A
SCHEMBL3904040 0.69 L3MBTL1 (0.50) CCNCCDK8L3MBTL1PKMRAB9A
SCHEMBL6032214 0.68 L3MBTL1 (0.53) L3MBTL1PKMRAB9AKDM4EMEN1
SCHEMBL27691514 0.68 TAAR1 (0.58) L3MBTL1RAB9ANSD2HSP90AA1G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154934-B1 COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THEIR USE IN TREATING NEURODEGENERATIVE DISEASES UNIV LILLE (FR) 2021-04-14 EP claimed